4
Changes in Ownership
Dolby Laboratories, Inc. Filed Acc 0000950170-24-131633
President and CEO sold 57,888 shares at an average $80.49 ($4,659,505)
- President and CEO acquired 57,888 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
YEAMAN KEVIN J · President and CEO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-25 | Exercise or conversion : show line 1 in the form 10b5-1 | +50,000 | $62.32 | $3,116,000 | 133,721 | I |
| 2024-11-25 | Sale : show line 2 in the form 10b5-1 | −49,104 | $80.53 | $3,954,232 | 84,617 | I |
| 2024-11-25 | Sale : show line 3 in the form 10b5-1 | −896 | $81.18 | $72,734 | 83,721 | I |
| 2024-11-26 | Exercise or conversion : show line 4 in the form 10b5-1 | +7,888 | $62.32 | $491,580 | 91,609 | I |
| 2024-11-26 | Sale : show line 5 in the form 10b5-1 | −7,888 | $80.19 | $632,539 | 83,721 | I |
| Open-market sales · 57,888 sh · avg $80.49 · $4,659,505 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-25 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (Right to Buy) | −50,000 | 7,888 | I |
| 2024-11-26 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Buy) | −7,888 | 0 | I |
Loading xslF345X05/ownership.xml…